Trial · NCT00943306
Registered outcomes54
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 54
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percent Change in Low Density Lipoprotein Cholesterol (LDL-C) | Baseline and Week 126 | Percent Change in Low Density Lipoprotein Cholesterol (LDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 126 (Week 48 in Study AEGR-733-012). |
| Secondary | Percent Change in Low Density Lipoprotein Cholesterol (LDL-C) | Baseline and Week 174 | Percent change in Low Density Lipoprotein Cholesterol (LDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 174 (Week 96 in Study AEGR-733-012). |
| Secondary | Percent Change in Low Density Lipoprotein Cholesterol (LDL-C) | Baseline and Week 222 | Percent change in Low Density Lipoprotein Cholesterol (LDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 222 (Week 144 in Study AEGR-733-012). |
| Secondary | Percent Change in Low Density Lipoprotein Cholesterol (LDL-C) | Baseline and Week 246 | Percent change in Low Density Lipoprotein Cholesterol (LDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 246 (Week 168 in Study AEGR-733-012). |
| Secondary | Percent Change in Low Density Lipoprotein Cholesterol (LDL-C) | Baseline and Week 270 | Percent change in Low Density Lipoprotein Cholesterol (LDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 270 (Week 192 in Study AEGR-733-012). |
| Secondary | Percent Change in Low Density Lipoprotein Cholesterol (LDL-C) | Baseline and Week 294 | Percent change in Low Density Lipoprotein Cholesterol (LDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 294 (Week 216 in Study AEGR-733-012). |
| Secondary | Percent Change in Total Cholesterol | Baseline and Week 126 | Percent change in Total Cholesterol from Baseline (Week 0 of Study 733-005/UP1002) to Week 126 (Week 48 in Study AEGR-733-012). |
| Secondary | Percent Change in Total Cholesterol | Baseline and Week 174 | Percent change in Total Cholesterol from Baseline (Week 0 of Study 733-005/UP1002) to Week 174 (Week 96 in Study AEGR-733-012). |
| Secondary | Percent Change in Total Cholesterol | Baseline and Week 222 | Percent change in Total Cholesterol from Baseline (Week 0 of Study 733-005/UP1002) to Week 222 (Week 144 in Study AEGR-733-012). |
| Secondary | Percent Change in Total Cholesterol | Baseline and Week 246 | Percent change in Total Cholesterol from Baseline (Week 0 of Study 733-005/UP1002) to Week 246 (Week 168 in Study AEGR-733-012). |
| Secondary | Percent Change in Total Cholesterol | Baseline and Week 270 | Percent change in Total Cholesterol from Baseline (Week 0 of Study 733-005/UP1002) to Week 270 (Week 192 in Study AEGR-733-012). |
| Secondary | Percent Change in Total Cholesterol | Baseline and Week 294 | Percent change in Total Cholesterol from Baseline (Week 0 of Study 733-005/UP1002) to Week 294 (Week 216 in Study AEGR-733-012). |
| Secondary | Percent Change in Apolipoprotein B (Apo B) | Baseline and Week 126 | Percent change in Apolipoprotein B (Apo B) from Baseline (Week 0 of Study 733-005/UP1002) to Week 126 (Week 48 in Study AEGR-733-012). |
| Secondary | Percent Change in Apolipoprotein B (Apo B) | Baseline and Week 174 | Percent change in Apolipoprotein B (Apo B) from Baseline (Week 0 of Study 733-005/UP1002) to Week 174 (Week 96 in Study AEGR-733-012). |
| Secondary | Percent Change in Apolipoprotein B (Apo B) | Baseline and Week 222 | Percent change in Apolipoprotein B (Apo B) from Baseline (Week 0 of Study 733-005/UP1002) to Week 222 (Week 144 in Study AEGR-733-012). |
| Secondary | Percent Change in Apolipoprotein B (Apo B) | Baseline and Week 246 | Percent change in Apolipoprotein B (Apo B) from Baseline (Week 0 of Study 733-005/UP1002) to Week 246 (Week 168 in Study AEGR-733-012). |
| Secondary | Percent Change in Apolipoprotein B (Apo B) | Baseline and Week 270 | Percent change in Apolipoprotein B (Apo B) from Baseline (Week 0 of Study 733-005/UP1002) to Week 270 (Week 192 in Study AEGR-733-012). |
| Secondary | Percent Change in Apolipoprotein B (Apo B) | Baseline and Week 294 | Percent change in Apolipoprotein B (Apo B) from Baseline (Week 0 of Study 733-005/UP1002) to Week 294 (Week 216 in Study AEGR-733-012). |
| Secondary | Percent Change in Triglycerides | Baseline and Week 126 | Percent change in Triglycerides from Baseline (Week 0 of Study 733-005/UP1002) to Week 126 (Week 48 in Study AEGR-733-012). |
| Secondary | Percent Change in Triglycerides | Baseline and Week 174 | Percent change in Triglycerides from Baseline (Week 0 of Study 733-005/UP1002) to Week 174 (Week 96 in Study AEGR-733-012). |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00943306/registered